Viewing Study NCT05842967


Ignite Creation Date: 2025-12-25 @ 12:55 AM
Ignite Modification Date: 2026-04-20 @ 5:52 AM
Study NCT ID: NCT05842967
Status: COMPLETED
Last Update Posted: 2025-08-08
First Post: 2023-04-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None RESPIRATORY SYNCYTIAL VIRUS (RSV) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None RESPIRATORY SYNCYTIAL VIRUS (RSV) View
None ADULTS AT HIGH RISK View
None IMMUNOCOMPROMISED ADULTS View